![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
October 14, 2021 -- InvestorsHub NewsWire -- via Hawk Point Media -- MarketWatch Winners, Inc. (OTC Pink: WNRS) shares are catching a bid after announcing licensing approvals...
Expects to Deploy First 100 Sensors to Hospitals and Research Facilities in the United States and New Zealand Vantage mHealthcare Inc., (OTCQB:VNTH) ("Vantage") or (the "Company") today...
Vantage mHealthcare Inc., (OTCQB:VNTH) ("Vantage") or (the "Company") today announced Vantage has extinguished debt owed to its parent company, Nanobeak. The Vantage Board, after...
Company Amends State of Incorporation to Delaware Vantage mHealthcare, Inc. (OTCQB:VNTH) (“Vantage Health” or the “Company”) today announced that the corporate name has officially changed...
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announces recent scientific updates and corporate developments. Over the last three months Vantage, and its...
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health") or (the "Company") today announced that it has entered into a strategic partnership with Theranostics Laboratory, a translational...
Vantage Health Inc., (OTCQB: VNTH) ("Vantage Health" or the “Company") today announced the appointment of Edward Rollins to its Board of Directors. Mr. Rollins currently serves as a...
Vantage Health Inc. (OTCQB:VNTH) ("Vantage Health" or the "Company") today announced the appointment of Joseph C. Peters to its Board of Directors, effective immediately. Mr. Peters will...
Vantage Health Inc., (OTCQB:VNTH) ("Vantage Health") or (the "Company") today announced the appointment of Steven R. Steinhubl, M.D. as chairman of the board. Dr. Steinhubl replaces interim...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions